Archives
-
2-Thio-dCTP for Precision DNA Workflows
2026-08-24
2-Thio-dCTP is a sulfur-modified DNA building block for testing polymerase selectivity, creating site-specific DNA modifications, and comparing DNA–protein recognition. This workflow-focused guide shows how to introduce the analog systematically while separating genuine biochemical effects from handling or assay artifacts.
-
Calpeptin: A Cell-Death-Aware Research Strategy
2026-08-24
Calpeptin is a potent calpain inhibitor for investigating how calcium-dependent protease activity shapes fibrosis, inflammation, and cell-death phenotypes. This guide presents a cell-death-aware assay framework for pulmonary fibrosis research, emphasizing causal interpretation rather than endpoint measurement alone.
-
8-Chloroadenosine for RNA Causality in NSCLC
2026-08-23
8-Chloroadenosine provides a temporal chemical perturbation for separating RNA synthesis from RNA decay in NSCLC models. This article develops an orthogonal assay strategy that complements RP3-340N1.2, ZC3H12A, and IL-6 mechanistic studies.
-
CARDIO Identifies HSPB7 Rescue in Titin Cardiomyopathy
2026-08-22
The reference study introduces CARDIO, a high-content morphological profiling assay for human stem cell-derived cardiomyocytes, and combines it with CRISPR gene perturbation and engineered heart tissue testing. This strategy identified HSPB7 depletion as a functional rescue of titin-associated cardiomyopathy phenotypes, while distinguishing it from the titin-like effects of YWHAE loss.
-
FGFR3 Inhibition in SLC26A2 Chondrodysplasia
2026-08-22
The reference study combines genetic ablation, inducible mouse models, chondrocyte assays, and pharmacological intervention to test whether excessive FGFR3 signaling contributes to SLC26A2-related chondrodysplasia. Its results show that NVP-BGJ398 can reduce abnormal downstream signaling and partially improve cartilage and skeletal phenotypes, supporting FGFR3 as a translational target while leaving important questions about human efficacy and treatment timing unresolved.
-
Pseudo-UTP for Reliable mRNA Workflows
2026-08-21
Learn how Pseudo-UTP (SKU B7972) can improve the design, interpretation, and reproducibility of pseudouridine-containing mRNA workflows. This scenario-based guide connects in vitro transcription decisions with downstream viability, proliferation, cytotoxicity, and expression assays while distinguishing documented evidence from practical recommendations.
-
PRINT: RNA-Mediated Safe-Harbor Insertion
2026-08-20
The reference study introduces PRINT, an RNA-only strategy that uses avian R2 retroelement proteins to insert transgenes at a multicopy human safe-harbor locus through target-primed reverse transcription. Its results support a potentially safer alternative to donor-DNA-dependent editing, although junction validation, transcript architecture, cell-type transferability, and long-term genomic behavior remain important limitations.
-
Vidarabine Monohydrate: Mechanism-to-Assay Design
2026-08-20
Vidarabine monohydrate is an adenosine-mimicking antiviral research compound for investigating viral DNA synthesis and replication. This article presents a mechanism-to-assay framework, informed by orthogonal screening principles from a recent SERT–nNOS study, to improve causal interpretation in herpes simplex virus research.
-
TH287 MTH1 Inhibitor: A Practical Research Workflow
2026-08-19
TH287 provides a high-potency way to investigate how oxidized nucleotide accumulation drives cancer-cell death and radiation response. This workflow translates recent CRPC findings into practical timing, assay, handling, and troubleshooting choices for reproducible MTH1 inhibition research.
-
RSAD2 at the SLE Maternal-Fetal Interface
2026-08-19
Ding et al. identify RSAD2 as a pathogenic interferon-stimulated gene that links excessive type I interferon activity with placental lipid accumulation, vascular injury, and impaired pregnancy development in systemic lupus erythematosus. By combining human maternal-fetal interface observations with genetic depletion and L-chicoric acid intervention in mouse models, the study provides a mechanistic basis for evaluating RSAD2 as a preclinical target.
-
RP3-340N1.2, IL-6, and NSCLC Progression
2026-08-18
This study identifies the lncRNA RP3-340N1.2 as a post-transcriptional regulator of IL-6 in non-small cell lung cancer. Its knockdown enhanced ZC3H12A-associated IL-6 mRNA degradation, reducing tumor-cell proliferation, migration, and tumor-associated macrophage polarization in cell-based models.
-
Dextrose (D-glucose) in Tumor Immunometabolism
2026-08-18
Use Dextrose (D-glucose) as a controlled nutrient variable to separate oxygen limitation from glucose availability in tumor and immune-cell assays. This workflow connects reproducible cell culture supplementation with actionable studies of glycolysis, metabolic competition, and immune suppression.
-
Aminopeptidase Selectivity and ACE Inhibitor Action
2026-08-17
This reference study directly compared metallopeptidase inhibitors across porcine kidney aminopeptidases A, N, and W, revealing substantial differences in inhibitor selectivity that are obscured by overlapping substrate preferences. Its findings provide a useful framework for interpreting ACE inhibitor experiments and for designing counter-screens before applying compounds such as Lisinopril dihydrate in disease-model workflows.
-
Phosbind Biotin LC: Practical PVDF Workflow
2026-08-17
Phosbind Biotin LC is a phosphate-binding reagent for sequence-independent detection of phosphorylated proteins on PVDF membranes, particularly when a suitable phospho-specific antibody is unavailable or insufficient. It is intended for Western Blot workflows using streptavidin-HRP and chemiluminescence, and should not be used in aqueous-only protocols or for long-term storage of working solutions.
-
Bestatin as a Chemical Genetic Probe of Jasmonate Signaling
2026-08-16
Zheng and colleagues showed that bestatin, an aminopeptidase inhibitor, activates jasmonate-responsive programs in tomato and Arabidopsis through a COI1-dependent pathway. By combining pharmacological treatments, transcriptomics, developmental phenotyping, and screening for bestatin-resistant mutants, the study established bestatin as a useful chemical-genetic probe for discovering regulators of jasmonate signaling.